Wang H, Zhou J, Ma X, Jiao C, Chen E, Wu Z et al (2023) Dexamethasone enhances venetoclax-induced apoptosis in acute myeloid leukemia cells. Med Oncol 40:193

Article  PubMed  Google Scholar 

Cerrano M, Chevret S, Raffoux E, Rabian F, Sébert M, Valade S et al (2023) Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis. Ann Hematol 102:761–768

CAS  PubMed  PubMed Central  Google Scholar 

Stalder G, Suffiotti M, Segot A, Noto A, Pantaleo G, Spertini O et al (2023) Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial. Haematologica 108:234–239

Article  PubMed  Google Scholar 

Cheng J, Liao Y, Bin T, Chen JOU, Chen S (2020) Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report. Curr Med Res Opin 36:1807–1812

Article  CAS  PubMed  Google Scholar 

Wooten DJ, Gebru M, Wang HG, Albert R (2021) Data-driven math model of FLT3-ITD acute myeloid leukemia reveals potential therapeutic targets. J Pers Med 11:193

Article  PubMed  PubMed Central  Google Scholar 

Moore DC, Nelson V, Muslimani A (2021) Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma. Ann Hematol 100:3053–3055

Article  CAS  PubMed  Google Scholar 

Hastings A, Apperley JF, Nadal-Melsio E, Brown L, Bain BJ (2021) Acute myeloid leukemia with a severe coagulopathy and t(8;16)(p11;p13). Am J Hematol 96:163–164

Article  PubMed  Google Scholar 

Bahmad HF, Gogola S, Elajami MK, Brathwaite C, Castellano-Sánchez AA, Sriganeshan V et al (2022) Hemophagocytic lymphohistiocytosis in the setting of therapy-induced acute myeloid leukemia: an autopsy report. Diseases 10:54

Article  PubMed  PubMed Central  Google Scholar 

Morita K, Kantarjian HM, Sasaki K, Issa GC, Jain N, Konopleva M et al (2021) Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib. Cancer 127:2641–2647

Article  CAS  PubMed  Google Scholar 

Šulavíková Z, Anwarzai J, Krásnik V (2022) Acute retinal necrosis after intravitreal dexamethasone implant. a case report. Cesk Slov Oftalmol 78:144–148

Gebru MT, Atkinson JM, Young MM, Zhang L, Tang Z, Liu Z et al (2020) Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia. Blood 136:1067–1079

Article  PubMed  PubMed Central  Google Scholar 

Hinds PS, Pinheiro LC, McFatrich M, Waldron M, Baker JN, Mowbray C et al (2022) Recommended scoring approach for the pediatric patient-reported outcomes version of the common terminology criteria for adverse events. Pediatr Blood Cancer 69:e29452

Article  PubMed  Google Scholar 

Bertoli S, Paubelle E, Bérard E, Saland E, Thomas X, Tavitian S et al (2019) Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia. Eur J Haematol 102:131–142

Article  CAS  PubMed  Google Scholar 

Jeon SY, Lee NR, Cha S, Yhim HY, Kwak JY, Jang KY et al (2023) Acute myelomonocytic leukemia and T-lymphoblastic lymphoma as simultaneous bilineage hematologic malignancy treated with decitabine: A case report. World J Clin Cases 11:5129–5135

Article  PubMed  PubMed Central  Google Scholar 

Ahmed HMM, Nimmagadda SC, Al-Matary YS, Fiori M, May T, Frank D et al (2022) Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells. Br J Haematol 196:995–1006

Article  CAS  PubMed  Google Scholar 

Mao J, Xue L, Wang H, Zhu Y, Wang J, Zhao L (2021) A new treatment strategy for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review. Onco Targets Ther 14:3795–3802

Article  PubMed  PubMed Central  Google Scholar 

Jaramillo AC, Bergman AM, Comijn EM, Jansen G, Kaspers GJL, Cloos J et al (2020) Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase. Nucleosides Nucleotides Nucleic Acids 39:1346

Article  CAS  PubMed  Google Scholar 

Wang L, Tang J, Feng J, Huang Y, Cheng Y, Xu H et al (2022) Case report: a rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations. Front Immunol 13:1001482

Article  CAS  PubMed  PubMed Central  Google Scholar 

Atas U, Aydin Ersoy M, Iltar U, Yucel OK, Turkoglu EB, Salim O (2022) Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia. J Oncol Pharm Pract 28:1474–1477

Article  CAS  PubMed  Google Scholar 

Huang AJ, Wang LB, Du J, Tang GS, Cheng H, Gong SL et al (2019) Efficacy of Hyper-CVAD/MA and CHALL-01 regimens in the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia patients under 60 years old. Zhonghua Xue Ye Xue Za Zhi 40:625–632

CAS  PubMed  Google Scholar 

Yanagisawa R, Kato M, Sakaguchi K, Nakagoshi R, Ogiso Y, Fukushima K et al (2020) A case of pure erythroid leukemia with MYB-GATA1 fusion that developed tumor lysis syndrome with dexamethasone. Pediatr Blood Cancer 67:e28285

Article  CAS  PubMed  Google Scholar 

Ramirez Melo JL, Cruz Osorio RM, Santoyo Cueva J, Sanchez Zubieta F, Chavez PA, Fernandez Mendoza LT et al (2021) Sweet syndrome in an adolescent patient with differentiation syndrome secondary to promyelocytic leukemia treatment with all-trans retinoic acid. J Med Cases 12:469–473

Article  PubMed  PubMed Central  Google Scholar 

Fischer D, Toenges R, Kiil K, Michalik S, Thalhammer A, Bug G et al (2024) Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia. Ann Hematol 103:489–498

Article  CAS  PubMed  Google Scholar 

Maioral MF, Stefanes NM, Bigolin Á, Zatelli GA, Philippus AC, de Barcellos Falkenberg M et al (2019) MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells. Invest New Drugs 37:912–922

Article  CAS  PubMed  Google Scholar 

Liu X, Liu YF, Zi JJ, Shu Y, Kong LZ, Zheng Q et al (2020) Effects of HAG combined with decitabine on the expression of inflammatory factors, HIF-1α and VEGF in patients with myelodysplastic syndrome. Hebei Med J 42:3123–3126

Google Scholar 

Nakagawa SI, Nukii Y, Mochizuki K, Uchiyama A, Maeda Y, Kurokawa T (2024) A case of peripheral T-cell lymphoma in which therapy-related myelodysplastic syndrome developed and a second autologous transplantation was performed. J Clin Exp Hematop 64:59–64

Article  PubMed  PubMed Central  Google Scholar